METTL3は,糖尿病性心筋病における運動の効果に不可欠である
Chunyan Wang1, Siman Shen1, Jiayi Kang1
1Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston (C.W., S.S., J.K., A.S.-M., X.X., Y.Z., J.Z., T.B.M., O.A., H.L.).
Circulation
|May 13, 2025
まとめ
運動は,N6-メチラデノシン (m6A) 改変に不可欠な酵素であるMETTL3を上調することによって,糖尿病性心筋病 (DiaCM) の心臓機能を向上させます. YBX1とNrf2を含むこの経路は,DiaCMのための新しい治療目標を提供します.
科学分野:
- 心血管生物学
- 分子医学
- エピジェネティクス
背景:
- 糖尿病性心筋病 (DiaCM) は 心臓の機能を損なっており 運動は有益ですが その背後にある分子メカニズムは 完全に理解されていません
- N6-メチラデノシン (m6A) RNAの改変は心臓の健康と疾患に作用するが,DiaCMと運動反応におけるその特定の関与は不明である.
研究 の 目的:
- N6-アデノシンメチルトランスフェラーゼ3 (METTL3) とその下流標的が糖尿病性心筋病 (DiaCM) の運動による心臓の効果に及ぼす役割を解明する.
- METTL3とYBX1をDiaCMの潜在的な治療標的として調査する.
主な方法:
- 人間のDiaCM患者および誘発DiaCMマウスモデルにおけるMETTL3およびm6Aレベルを調査し,運動効果とMETTL3操作 (ノックアウト/過剰発現) を評価した.
- YBX1を中心にMETTL3のダウンストリームエフェクターを特定するためにRNA配列を解析し,DiaCM心筋細胞における過剰発現/ノックダウンによるYBX1の役割を調べた.
- 小分子によるMETTL3活性化がDiaCMにおける心臓機能に与える影響を評価した.
主要な成果:
- 心臓のMETTL3およびm6A濃度はDiaCM患者およびマウスで低下したが,運動によって増加した.
- METTL3過剰発現は心臓機能を改善し,ノックアウトは運動の効果を廃止した.
- METTL3は,m6Aに依存した方法でYBX1をアップ調節し,Nrf2を活性化し,酸化ストレスを軽減し,YBX1過剰発現によって模倣され,YBX1ノックダウンによってブロックされた.
結論:
- METTL3は,DiaCMにおける運動の心臓保護効果に不可欠です.
- METTL3によるYBX1のアップレギュレーションと,その後のNrf2のアクティベーションは,DiaCMにおける運動効果の鍵となるメカニズムです.
- METTL3とYBX1は,糖尿病性心筋病の治療における有望な治療標的として特定されています.
関連する概念動画
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32